AU571038B2 - Ophthalmic gel - Google Patents

Ophthalmic gel

Info

Publication number
AU571038B2
AU571038B2 AU36660/84A AU3666084A AU571038B2 AU 571038 B2 AU571038 B2 AU 571038B2 AU 36660/84 A AU36660/84 A AU 36660/84A AU 3666084 A AU3666084 A AU 3666084A AU 571038 B2 AU571038 B2 AU 571038B2
Authority
AU
Australia
Prior art keywords
ophthalmic gel
injectionable
polymethacrylamide
continuation
serial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36660/84A
Other languages
English (en)
Other versions
AU3666084A (en
Inventor
Victoria S. Chylinski
Seymour F. Trager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHYLINSKI V S
Trager S F
Original Assignee
CHYLINSKI V S
Trager S F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHYLINSKI V S, Trager S F filed Critical CHYLINSKI V S
Publication of AU3666084A publication Critical patent/AU3666084A/en
Application granted granted Critical
Publication of AU571038B2 publication Critical patent/AU571038B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AU36660/84A 1984-06-27 1984-12-13 Ophthalmic gel Ceased AU571038B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US625249 1984-06-27
US06/625,249 US4540568A (en) 1982-10-14 1984-06-27 Injectionable viscoelastic ophthalmic gel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU10009/88A Division AU601254B2 (en) 1984-06-27 1988-01-07 Ophthalmic surgical method

Publications (2)

Publication Number Publication Date
AU3666084A AU3666084A (en) 1986-01-02
AU571038B2 true AU571038B2 (en) 1988-03-31

Family

ID=24505208

Family Applications (2)

Application Number Title Priority Date Filing Date
AU36660/84A Ceased AU571038B2 (en) 1984-06-27 1984-12-13 Ophthalmic gel
AU10009/88A Ceased AU601254B2 (en) 1984-06-27 1988-01-07 Ophthalmic surgical method

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU10009/88A Ceased AU601254B2 (en) 1984-06-27 1988-01-07 Ophthalmic surgical method

Country Status (7)

Country Link
US (1) US4540568A (cg-RX-API-DMAC7.html)
EP (1) EP0166061B1 (cg-RX-API-DMAC7.html)
JP (1) JPS6113957A (cg-RX-API-DMAC7.html)
AT (1) ATE60998T1 (cg-RX-API-DMAC7.html)
AU (2) AU571038B2 (cg-RX-API-DMAC7.html)
CA (1) CA1238278A (cg-RX-API-DMAC7.html)
DE (1) DE3484203D1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713446A (en) * 1985-09-06 1987-12-15 Minnesota Mining And Manufacturing Company Viscoelastic collagen solution for ophthalmic use and method of preparation
US4851513A (en) * 1985-09-06 1989-07-25 Minnesota Mining And Manufacturing Company Viscoelastic collagen solution for opthalmic use and method of preparation
US4883864A (en) * 1985-09-06 1989-11-28 Minnesota Mining And Manufacturing Company Modified collagen compound and method of preparation
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
WO1988009665A1 (en) * 1987-06-01 1988-12-15 Allergan, Inc. Preservative free ophthalmic ointments
US4828828A (en) * 1987-07-28 1989-05-09 Trager Seymour F Method of treating degenerative joint disease by injection of meth(acrylamide) (co)-polymers
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
US4909784A (en) * 1988-03-25 1990-03-20 Seymour Dubroff Method for preventing clouding of posterior capsule after extracapsular cataract eye surgery
US5271943A (en) * 1989-10-27 1993-12-21 Scott Health Care Wound gel compositions containing sodium chloride and method of using them
ATE106531T1 (de) * 1989-12-08 1994-06-15 Skandinavisk Miljo System As Einrichtung zur luftbefeuchtung.
US5103840A (en) * 1990-05-07 1992-04-14 Kavoussi Harold P Viscoelastic collagen gel for ophthalmic surgery
US5323775A (en) * 1991-09-13 1994-06-28 Allergan, Inc. Diagnostic method for determining precorneal retention time of ophthalmic formulations
HUT66957A (en) * 1991-10-16 1995-01-30 Richardson Vicks Inc Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
CA2120927A1 (en) * 1991-10-16 1993-04-29 George E. Deckner Enhanced skin penetration system for improved topical delivery of drugs
EG20380A (en) 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
CA2141192C (en) * 1992-07-28 1999-02-02 Roberta C. Bloom Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
US5989536A (en) * 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
UA10911C2 (uk) * 1994-08-10 1996-12-25 Мале Впроваджувальне Підприємство "Іhтерфалл" Біосумісhий гідрогель
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
DK1418188T3 (da) * 2000-08-25 2010-02-08 Contura As Polyacrylamid-hydrogel og dets anvendelse som endoprotese
US7186419B2 (en) 2000-08-25 2007-03-06 Contura Sa Polyacrylamide hydrogel for arthritis
WO2003000231A1 (en) * 2001-06-22 2003-01-03 Alcon, Inc. Hydration compositions for corneal pre-surgery treatment
RU2192860C1 (ru) * 2001-07-04 2002-11-20 Общество с ограниченной ответственностью "Научно-экспериментальное производство Микрохирургия глаза" Мазь для лечения блефаритов и блефароконъюнктивитов
CN104523575B (zh) * 2014-12-24 2017-09-26 昆明振华制药厂有限公司 一种盐酸羟苄唑眼用凝胶剂及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920810A (en) * 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
US3978201A (en) * 1972-11-27 1976-08-31 Gennady Lvovich Khromov Base for ophthalmological medicinal preparation on opthalmological medicinal film
AU2230983A (en) * 1982-12-13 1984-06-21 Wyeth Holdings Corporation Anthelmintic gel composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE375007B (cg-RX-API-DMAC7.html) * 1972-11-30 1975-04-07 Pharmacia Ab
CH618092A5 (en) * 1974-04-23 1980-07-15 Vnii Khirurgicheskoi Apparatur Process for the production of a biosoluble basic composition for ophthalmological films
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
US4271144A (en) * 1979-06-06 1981-06-02 Holles Laboratories, Inc. Dextran composition for controlling corneal hydration
DE3050012A1 (de) * 1979-11-06 1982-05-06 I Bilko Polyacrylamide gel for medical and biological application and method of its preparation
EP0014238A3 (de) * 1979-11-23 1980-10-29 Albert E. Posthuma Schleimbildendes synthetisches Schmier- und Gleitmittel, insbesondere für den Vaginalbereich, und dessen Verwendung im Bereich der diagnostischen, chirurgischen und behandelnden Medizin
JPS59101421A (ja) * 1982-11-29 1984-06-12 Kaken Pharmaceut Co Ltd 眼科用潅流液

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978201A (en) * 1972-11-27 1976-08-31 Gennady Lvovich Khromov Base for ophthalmological medicinal preparation on opthalmological medicinal film
US3920810A (en) * 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
AU2230983A (en) * 1982-12-13 1984-06-21 Wyeth Holdings Corporation Anthelmintic gel composition

Also Published As

Publication number Publication date
US4540568A (en) 1985-09-10
EP0166061B1 (en) 1991-02-27
CA1238278A (en) 1988-06-21
EP0166061A3 (en) 1987-01-07
AU3666084A (en) 1986-01-02
JPH0455070B2 (cg-RX-API-DMAC7.html) 1992-09-02
AU1000988A (en) 1988-04-28
AU601254B2 (en) 1990-09-06
ATE60998T1 (de) 1991-03-15
JPS6113957A (ja) 1986-01-22
EP0166061A2 (en) 1986-01-02
DE3484203D1 (de) 1991-04-04

Similar Documents

Publication Publication Date Title
AU571038B2 (en) Ophthalmic gel
EP0308021A3 (en) Subsituted thieno (2,3-b)pyrole-5-sulfonamides as antiglaucoma agents
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
AU7317387A (en) Use of tetrahydrocortisol in glaucoma therapy
AU7266991A (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
PH25503A (en) Method of medical treatment
MY102323A (en) New ribofuranuronic acid derivatives
EP0679717A3 (en) Soluble interferon receptor, its production and use.
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
AU6317190A (en) Contact lens from hydrophilic gels
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
SG61993G (en) Ophthalmic gel composition and method of treating eye infections
AU1726088A (en) Improved viscoelastic fluid for ophthalmic surgery and method of using same
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
DE3886314D1 (de) Substituierte Thieno(2,3-b) thiophen-2-sulfonamide als Mittel gegen Glaukoma.
GR3000751T3 (en) Tpa-containing medical composition and use thereof
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
AU1966988A (en) Ophthalmic agent and related compositions and method for treatment of the cornea
EP0309028A3 (en) Substituted thieno(2,3-b)furan-2-sulfonamides as antiglaucoma agents
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.